American Society of Tropical Medicine and Hygiene (ASTMH), 65th Annual Meeting
November 13 – 17, 2016
Atlanta, Georgia USA
DNDi will be presenting in symposia on sleeping sickness and Chagas disease, as well as co-authoring poster presentations on filarial diseases.
European & Developing Countries Clinical Trials Partnership
November 6-9, 2016
Nathalie Strub-Wourgaft, Medical Director, DNDi, will be speaking at the event.
October 17-18, 2016
São Paulo, Brazil
The 10th ENIFarMed event will focus on access to medicines by exploring public access policies. Joël Keravec, Regional Executive Director of DNDi Latin America will participate in the event.
September 20-22, 2016
Antoine Tarral, Head of HAT Clinical Program, DNDi, Christelle Perdieu, Clinical Project Manager, DNDi and Olaf Valverde, Medical Manager, DNDi, presented at the event.
September 18-22, 2016
Robert Don, Discovery & Preclinical Director, DNDi and Eduard Ziljstra, Senior Consultant, DNDi presented at this event.
International Collaborative Research Program for Tackling the NTDs Challenges in African Countries
September 15-16, 2016
Monique Wasunna, Director, DNDi Africa and Tatsuro Kuzuki, Scientific Liaison, DNDi Japan presented at the event.
Pharmaceutical Sciences: Improving World Health
September 5-7, 2016
Steve Robinson, Head of Pharmaceutical Development at DNDi, presented on neglected diseases.
XXIV EFMC International Symposium on Medicinal Chemistry
August 28-September 1, 2016
Benjamin Perry, Project Manager NTD Drug Discovery Booster, and Charles Mowbray, Head of Drug Discovery, co-authored a poster about the NTD Drug Discovery Booster presented at the symposium.
Doenças urbanas e mundiais
August 21-24, 2016
DNDi participated in the 52nd Congress of the Brazilian Society of Tropical Medicine.
21st International AIDS Conference
July 18-22, 2016
Durban, South Africa
DNDi, CHAI, UNITAID, and NEPHAK held an AIDS 2016 Satellite Session to share practical and programmatic experience developing and introducing new paediatric ARV formulations.
June 21-24, 2016
The 29th edition of soIPa National Congress focused on the most important parasitoses of medical and veterinary interest and their impact, particularly in developing countries where poor conditions and lack of economic resources may limit public health policies.
Ivan Scandale, Project Manager, presented on new molecules for parasites.
June 7-10, 2016
PAGE represents a community with a shared interest in data analysis using the population approach. Each year a meeting is held in June at a different European location. Stephanie Braillard, Project Manager, DNDi and Charles Mowbray, Head of Drug Discovery, DNDi presented a poster at the event.
June 6-8, 2016
Rio de Janeiro, Brazil
DNDi Latin America organized a series of events with conferences, discussions and meetings. International scientists, product developers, policy-makers, and civil society organizations, participated in the events in order to do the best science for the most neglected.
May 25-26, 2016
London, United Kingdom
Eric Chatelain, Head of Drug Discovery, presented on drug discovery and development for Chagas disease.
GHTC Panel Discussion
May 23, 2016
A lunchtime panel discussion and webinar hosted by the Global Health Technologies Coalition and the Geneva Centre for Security Policy. Bernard Pécoul, Executive Director, DNDi spoke at the event.
May 18-20, 2016
Graeme Bilbe, R&D Director, spoke at this scientific conference celebrating the tenth anniversary of the Dundee Drug Discovery Unit.
April 25, 2016
The Swiss Malaria Group marked the occasion of World Malaria Day 2016 in Bern. The group informed the public about the commitment of the Swiss Malaria Group Association in the fight against malaria and about the devastation still caused by malaria in the world.
April 19-21, 2016
Carolina Batista, Regional Medical Manager, and Andrea Marchiol, Coordinator for the Chagas Operational Projects, presented on access to treatment for Chagas disease.
April 15-17, 2016
Byron Arana, Head of Cutaneous Leishmaniasis, DNDi presented on DNDi‘s cutaneous leishmaniasis strategy.
April 13-17, 2016
DNDi launched its new Research & Development Strategy for Hepatitis C at the International Liver Congress (ILC) on April 13th.